🔎 Trials Near Me

Home › Triple-Negative Breast Cancer › Nevada › Las Vegas

Triple-Negative Breast Cancer clinical trials in Las Vegas, NV

5 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Las Vegas (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

RecruitingPhase 3
  • Comprehensive Cancer Centers of Nevada ( Site 0015), Las Vegas
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06841354

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

RecruitingPhase 3
  • Optum Care Cancer Center ( Site 9535), Las Vegas
  • Comprehensive Cancer Centers of Nevada - Peak ( Site 0047), Las Vegas
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06393374

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

RecruitingPhase 3
  • Optum Care Cancer Center ( Site 0050), Las Vegas
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06966700

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

RecruitingPhase 1
  • Comprehensive Cancer Centers of Nevada, Las Vegas
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT07029399

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

RecruitingPhase 1/2
  • Comprehensive Cancer Centers of Nevada, Las Vegas
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05377996

Triple-Negative Breast Cancer trials in other cities

Other studies in Las Vegas

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.